---
title: AHCC07
permalink: /ahcc/completed-trails/ahcc07/
description: ""
third_nav_title: Completed Trials
variant: tiptap
---
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p><strong>AHCC 07</strong>
</p>
</th>
<th rowspan="1" colspan="1">
<p>Precision Medicine in Liver Cancer across an Asia-Pacific Network (The
PLANet Study) (NCT03267641)</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Status</p>
</td>
<td rowspan="1" colspan="1">
<p>Updated data as of June 2025 showed that 187 of 277 patients have reached
the study end-points (as defined by recurrence or death, or completion
of 3 years follow-up from date of surgery).</p>
<p>Two main publications in <em>Cell</em> (DOI: 10.1016/j.cell.2020.08.040)
and <em>Nature Communications</em> (DOI: 10.1038/s41467-020-20171-7).</p>
<p>Patent:</p>
<ol data-tight="true" class="tight">
<li>
<p>A system and method for classifying cancer patients into appropriate cancer
treatment groups and compounds for treating the patient (Valerie Chew,
Pierce Chow, Albani Salvatore) (Application number: 10201709924T; Filing
Date: 30/11/2017)</p>
</li>
<li>
<p>Cell-based biomarkers of immunotherapy in hepatocellular carcinoma (Ankur
Sharma, Florent Ginhoux, Ramanuj Dasgupta, Pierce Chow) (Singapore Provisional
Application number.: 10202007868Q; Filing Date: 17/08/2020)</p>
<p></p>
</li>
</ol>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Contributing Principal
<br>Investigators and Centres</p>
<p></p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Malaysia</strong>
</p>
<p>Yoong Boon Koon (University Malaya Medical Center)</p>
<p><strong>Philippines</strong>
</p>
<p>Maria Vanessa H. de Villa (The Medical City)</p>
<p><strong>Singapore</strong>
</p>
<p>Pierce Chow (National Cancer Centre), Glenn Bonney (National University
Hospital), Brian Goh (Singapore General Hospital)</p>
<p><strong>Thailand</strong>
</p>
<p>Rawisak Chanwat (National Cancer Institute)</p>
<p><strong>United States of America</strong>
</p>
<p>Sabino Zani Jr (Duke University School of Medicine)</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Thematic Principal Investigators</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Theme: Genomic evolution in HCC and the discovery of novel drug targets</strong>
</p>
<p>Name: Zhai Weiwei</p>
<p>Designation: Senior Research Scientist</p>
<p>Institution: Genome Institute of Singapore</p>
<p></p>
<p><strong>Theme: Translational Immunomics: Immune-phenotyping, monitoring and discovery of novel immunotherapies</strong>
</p>
<p>Name: Salvatore Albani</p>
<p>Designation: Director</p>
<p>Institution: SingHealth Translational Immunology and Inflammation Centre</p>
<p></p>
<p><strong>Theme: Clinical Trajectory and Translational Therapeutics</strong>
</p>
<p>Name: Pierce Chow</p>
<p>Designation: Senior Consultant</p>
<p>Institution: National Cancer Centre</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Protocol Chair</p>
</td>
<td rowspan="1" colspan="1">
<p>Pierce Chow
<br><a href="mailto:pierce.chow@duke-nus.edu.sg" rel="noopener noreferrer nofollow" target="_blank">pierce.chow@duke-nus.edu.sg</a>
</p>
</td>
</tr>
</tbody>
</table>
<p></p>